Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended February 2026 · cache
- 100,000 shares@ CA$1.52OptionsTSXSEDI:4795004
- 120,000 shares@ CA$1.52OptionsTSXSEDI:4794998
- 1,000,000 shares@ CA$1.52OptionsTSXSEDI:4794976
- 50,000 shares@ CA$1.000.015% mcap4.2% of flowCommon SharesTSXSEDI:4794367
- 25,000 shares@ CA$0.350.8% of flowOptionsTSXSEDI:4785986
- 52,000 shares@ CA$1.9140.025% mcap1.1% of flowCommon SharesTSXSEDI:4762987
- 123,000 shares@ CA$1.980.061% mcap2.8% of flowCommon SharesTSXSEDI:4762986
- 340,000 shares@ CA$1.750.15% mcap6.8% of flowCommon SharesTSXSEDI:4762984
- 174,000 shares@ CA$2.040.089% mcap4.0% of flowCommon SharesTSXSEDI:4762983
- 194,100 shares@ CA$2.1350.10% mcap4.7% of flowCommon SharesTSXSEDI:4762982
- 288,800 shares@ CA$2.060.15% mcap6.8% of flowCommon SharesTSXSEDI:4762981
- 1,275,000 shares@ CA$0.550.17% mcap8.0% of flowCommon SharesTSXSEDI:4760862
- 1,275,000 sharesOptionsTSXSEDI:4760860
- 500,000 shares@ CA$2.000.25% mcap11.4% of flowCommon SharesTSXSEDI:4754588
- 135,400 shares@ CA$2.03430.069% mcap3.2% of flowCommon SharesTSXSEDI:4754587
- 135,600 shares@ CA$2.01760.069% mcap3.1% of flowCommon SharesTSXSEDI:4754586
- 187,700 shares@ CA$2.06170.097% mcap4.4% of flowCommon SharesTSXSEDI:4754585
- 100,000 shares@ CA$2.55100.0% of flowOptionsTSXSEDI:4724944
- 450,000 shares@ CA$2.55100.0% of flowOptionsTSXSEDI:4724942
- 1,500,000 shares@ CA$2.5543.7% of flowOptionsTSXSEDI:4724939
- 475,000 shares@ CA$0.552.7% of flowCommon SharesTSXSEDI:4721477
- 250,000 shares@ CA$2.70517.1% of flowCommon SharesTSXSEDI:4721473
- 402,826 shares@ CA$0.5519.3% of flowCommon SharesTSXSEDI:4719493
- 2,700 shares@ CA$1.940.4% of flowCommon SharesTSXSEDI:4688899
- 10,000 shares@ CA$2.612.8% of flowCommon SharesTSXSEDI:4670514
25 of 177 declarations
About Doubleview Gold Corp.
At Doubleview Gold Corp., selling is the rule: 85 sales worth EUR 4,128,879 (median EUR 12,995) against 3 purchases worth EUR 209,763, or 3% purchases among open-market trades. Farshad Shirvani, a director, signed the three largest sales, EUR 369,450 on August 10, 2026, EUR 329,352 on October 16, 2025 and EUR 257,137 on August 7, 2026, as well as the two largest purchases, EUR 105,486 on March 27, 2025 and EUR 74,668 on April 12, 2023. The third purchase, EUR 29,608, is by Andrew H. Rees, a director, on June 2, 2025.
Three filers account for most of the sales: Andrew H. Rees (25 sales across 36 filings), Christopher Padraig Cherry, a senior officer (25 across 36) and Farshad Shirvani (21 across 39). Hugh Maddin, a director, has 12 across 13.
Read moreShow less
This Canadian chemicals company, with a market capitalisation of CAD 343.7 million and 17.1% held by insiders, has 134 filings published from February 8, 2021 to October 2, 2026. The year 2025 holds 87, against 12 in 2021 and 7 in 2024. There are 32 option exercises. Over the last twelve months, 43 filings including 1 purchase and 30 sales. Median publication delay: 4 days.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
